BioRestorative Therapies Inc (BRTX)
NASDAQ NMS - GLOBAL MARKET · Biotechnology
$0.27-0.01 (-3.75%)Quote refreshed
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
$6.8M
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
No company overview is available for BioRestorative Therapies Inc yet.
Peers in Biotechnology
All in industry →VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%
Recent press releases
BioRestorative Therapies Inc has not issued a press release in this window.
SEC filings
All filings →BioRestorative Therapies Inc has not filed an SEC document in this window.
Insider trades
All insider trades →BioRestorative Therapies Inc has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
1 sh-98.8%
11 sh-8.3%
1 sh0.0%
People at BioRestorative Therapies Inc
All people →Quarterly financials
Full financials →Revenue trend
03/25
$25.0K
NI -$5.3M
06/25
$3.3K
NI -$2.7M
09/25
$11.8K
NI -$3.0M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.33
Prior: $-0.30
Revenue sparkline